Acceder

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...
Sabater Molina M, Nicolas Rocamora E, Bendicho AI, Vazquez EG, Zorio E, Rodriguez FD, Gil Ortuno C, Rodriguez AI, Sanchez-Lopez AJ, Jara Rubio R, Moreno-Docon A, Marcos PJ, Garcia Pavia P, Villa RB, Gimeno Blanes JR. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease. PLoS One. 2022 Feb 4;17(2):e0263140. doi: 10.1371/journal.pone.0263140. eCollection 2022. PubMed PMID: 35120165; PubMed Central PMCID: PMC8815985.
AÑO: 2022; IF: 3.7
35120165
Rodriguez-Manero M, Baluja A, Hernandez J, Munoz C, Calvo D, Fernandez-Armenta J, Garcia-Fernandez A, Zorio E, Arce-Leon A, Sanchez-Gomez JM, Mosquera-Perez I, Arias MA, Diaz-Infante E, Exposito V, Jimenez-Ramos V, Teijeira E, Canadas-Godoy MV, Guerra-Ramos JM, Oloriz T, Basterra N, Sousa P, Elices-Teja J, Garcia-Bolao I, Gonzalez-Juanatey JR, Brugada R, Gimeno JR, Brugada J, Arbelo E. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study. Rev Esp Cardiol (Engl Ed). 2022 Jul;75(7):559-567. doi: 10.1016/j.rec.2021.07.007. Epub 2021 Sep 1. English, Spanish. PubMed PMID: 34479845.
AÑO: 2022; IF: 5.9
34479845
Lopez-Galvez R, Rivera-Caravaca JM, Anguita Sanchez M, Sanmartin Fernandez M, Rafols C, Perez-Cabeza AI, Baron Esquivias G, Lekuona Goya I, Vazquez Rodriguez JM, Cosin Sales J, Arribas Ynsaurriaga F, Barrios V, Freixa-Pamias R, Marin F. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study. Eur J Clin Invest. 2022 Sep;52(9):e13788. doi: 10.1111/eci.13788. Epub 2022 Apr 14. PubMed PMID: 35395094.
AÑO: 2022; IF: 5.5
35395094
Vitolo M, Malavasi VL, Proietti M, Diemberger I, Fauchier L, Marin F, Nabauer M, Potpara TS, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Lane DA, Lip GYH, Boriani G; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry. Eur J Intern Med. 2022 May;99:45-56. doi: 10.1016/j.ejim.2022.01.025. Epub 2022 Feb 15. PubMed PMID: 35177307.
AÑO: 2022; IF: 8.0
35177307
Boriani G, Vitolo M, Malavasi VL, Proietti M, Fantecchi E, Diemberger I, Fauchier L, Marin F, Nabauer M, Potpara TS, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Lane DA, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry. Eur J Prev Cardiol. 2022 Nov 8;29(15):1967-1981. doi: 10.1093/eurjpc/zwac115. PubMed PMID: 35671129.
AÑO: 2022; IF: 8.3
35671129
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

CARDIOLOGIA CLINICA Y EXPERIMENTAL